$XALL is taking a high value position in the worldwide

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
191
$XALL is taking a high value position in the worldwide Metadata and Artificial Intelligence solutions field with its recent acquisition.

Xalles Enters Global Metadata Management Solutions Business with Adaptive Acquisition

WASHINGTON, DC, July 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Xalles Holdings Inc. (OTC: XALL), a Fintech holding company providing technology and financial services solutions, today announces that it has executed a Share Exchange Agreement to acquire 100% of Adaptive Metadata Solutions Inc. (“Adaptive”). Adaptive Metadata Solutions is a Master Reseller of Adaptive products and provides industry leading metadata analytics (data that describes other data), and artificial intelligence solutions to large enterprises.

Adaptive provides Fortune 500 clients with essential software solutions that deliver a business discipline of data governance, control and innovation to the enterprise. Industries currently serviced include Insurance, Financial Services, Government Agencies, Healthcare, Energy, and many other regulated industries, where compliance and data governance are critical to operational and strategic success. Adaptive is projected to generate at least $5 million in 2020 revenue and more than $10 million in revenue in 2021.

Collectively, Adaptive’s product suite is used by clients that include Bank of America, Federal Reserve Bank of New York, Western Union, the U.S. Government’s General Accounting Office (GAO), Dell, United Natural Foods, and numerous central banks and financial services companies. The cloud based or on-premises Adaptive platform enables organizations to understand the entire data landscape of an enterprise providing end-to-end data lineage analytics. Gartner named Adaptive’s platform as a Leader in its 2019 Magic Quadrant for Metadata Management Solutions. Clients leverage the Adaptive platform for enhanced data governance, analytics, Artificial Intelligence and Machine Learning best practices and reuse.

Adaptive Metadata Solutions Inc. is led by its CEO, Eric Reehl. Mr. Reehl has over 25 years of experience as an investor and advisor to companies, lenders, and investors across a range of industries for both debt and equity capital. He has led in excess of $5 billion of direct investments and restructurings as a principal or advisor. He previously served as a Managing Director for Plainfield Asset Management LLC, a $5.2 billion Greenwich, Connecticut-based hedge fund. He received his Master’s Degree in Business and undergraduate degree from the University of Texas at Austin.

Adaptive’s CEO commented, “The Adaptive and Xalles relationship will facilitate our growth in multiple vertical markets to build upon our successful client implementations. Adaptive is perfectly positioned for rapid global growth in the next 2 years through our alliances and channel partners, which account for a significant number of our business referrals.”

“The Adaptive acquisition is the definition of synergy. Adaptive will add value to our existing operating companies and technologies, while Argus Technology Partners will expand Adaptive’s reach into new vertical markets,” stated Thomas Nash, Xalles Holdings CEO. “We have a unique opportunity to cross sell our products between companies. Adaptive’s offerings will create additional opportunities that will enable our client base to achieve tremendous savings and compliance benefits through data analytics, and artificial intelligence to support governance applications and cyber security. The real value proposition of this acquisition to our shareholders comes in the form of building a recurring revenue stream with a growing base of blue chip clientele as we complete our current fundraising effort.”

Xalles Technology Inc., a wholly owned subsidiary of Xalles Holdings Inc., will acquire all of the shares of Adaptive Metadata Solutions Inc., making Adaptive a wholly owned subsidiary of Xalles Technology. The acquisition agreement defines the closing date for this transaction as on or before August 10, 2020.

About Xalles Holdings Inc. (OTC: XALL)

Xalles Holdings Inc. is a holding company that focuses on acquisition and support of disruptive fintech companies. The company actively seeks targets in which it can partner with or acquire to accelerate growth, targeting companies with solid management teams and business models, large total attainable markets (TAM), and lucrative exit opportunities. The company places an emphasis on leveraging blockchain technologies to provide industry-leading financial reconciliation and auditing solutions, which, over time, will allow for the capture of recurring revenue streams. For more information visit: http://Xalles.com

About Adaptive

Adaptive Metadata Solutions Inc. is headquartered in Dallas, Texas. The Adaptive platform was named by Gartner as a leader in the 2019 Magic Quadrant for Metadata Management Solutions along with Oracle, IBM, Infomatica, and SAP. Adaptive is a market leader with a long history of helping simplify the complex data that organizations generate by adapting and eliminating the time consuming and expensive tasks of managing corporate information. The company’s offerings are designed to support the rapidly changing business and IT environments, which are driven by the ever increasing demands of compliance, regulatory pressures and governance requirements. Adaptive provides innovative solutions that enable enterprises to align their capabilities with strategic intent. Adaptive offers standards-based solutions that help organizations better align their valuable information by supporting specific management challenges including Data Governance, Data Quality, Metadata Management, Enterprise Architecture Management and IT Portfolio Management while ensuring Knowledge is retained as systems evolve. For more on the Adaptive product suite, visit http://www.adaptive.com

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov and in OTC Markets at www.otcmarkets.com

Investor Relations Contact:

Info@Xalles.com

www.Xalles.com

202.595.1299 Office

Corporate Communications:

NetworkNewsWire (NNW)

New York, New York

www.NetworkNewsWire.com

212.418.1217 Office

Editor@NetworkWire.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Jeff McLean Takes the Helm as ghSMART's New CEO

Updated Category News Views 620

Jeff McLean Takes the Helm as ghSMART's New CEO G.H. Smart & Company, LLC, the leading firm in leadership advisory, proudly announces the appointment of Jeff McLean as the Chief Executive Officer. McLean, who has been serving as President of ghSMART for three years, will now guide the firm towards its next exciting phase of growth and innovation. Achievements Under...

Continue Reading
Growth Forecast for Hot Dog and Sausage Market to 2032

Updated Category News Views 51

Introduction to the Hot Dog and Sausage Market The global market for hot dogs and sausages is witnessing a remarkable upward trajectory, with projections estimating it will reach USD 112.41 billion by 2032. This growth is fueled by a compound annual growth rate (CAGR) of 3.50%. The factors contributing to this expansion are numerous, including shifting consumer...

Continue Reading
Exro Technologies Adjusts Leadership with New CEO Plans

Updated Category News Views 337

Exro Technologies Announces Leadership Changes Exro Technologies Inc. has made a significant announcement regarding its leadership structure. Following the resignation of Sue Ozdemir from her role as Chief Executive Officer, the company has initiated steps to ensure a seamless transition and continuity in leadership. New Chief Restructuring Officer Appointed Introduction...

Continue Reading
Hillenbrand Increases Quarterly Dividend to $0.225 Per Share

Updated Category News Views 208

Hillenbrand's Exciting Dividend Announcement The board of directors of Hillenbrand, Inc. (NYSE: HI) has proudly announced a regular cash dividend of $0.225 per share on its common stock. This announcement signifies an annual increase of $0.01, bringing the total dividend rate to $0.90 per share for fiscal 2025. Such a commitment underlines Hillenbrand's dedication to...

Continue Reading
Trump's World Liberty Financial Token Sale Raises $220 Million

Updated Category News Views 113

Trump's World Liberty Financial Token Sale Demonstrates Huge Demand The World Liberty Financial project, closely associated with Donald Trump, made headlines recently as its token sale reached an impressive $220 million in just the first hour. Despite facing multiple outages on its website, the initiative showcased remarkable demand and interest. Details of the Token Sale...

Continue Reading